Clinical trials
Phase 2 Supranuclear Palsy, Progressive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Completed | 2 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adam Boxer | 3 |
| AbbVie | 2 |
| Biogen | 1 |
| Ferrer Internacional S.A. | 1 |
| Loma Linda University | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Transposon Therapeutics, Inc. | 1 |
| Woolsey Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Supranuclear Palsy, Progressive | 11 |
| Frontotemporal Dementia | 2 |
| Tauopathies | 2 |
| Corticobasal Degeneration | 1 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Multiple System Atrophy | 1 |
| Neurodegenerative Diseases | 1 |
| Parkinson Disease | 1 |
| Parkinsonian Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.